After a year of NAFTA renegotiations, in the fall of 2018 a revised text was released. It revealed some improvements that progressives have long demanded, such as a major rollback of Investor-State Dispute Settlement. But NAFTA 2.0 also includes unacceptable new powers for pharmaceutical firms to keep medicine prices high. And critically, more work is needed to strengthen labor and environmental standards and ensure their swift and certain enforcement.
Current Status of the Fight to Replace NAFTA
Learn more about the how we're fighting to replace NAFTA with a better deal for workers and the environment.
Call Congress: No Vote on NAFTA 2.0 Until It's Fixed
We call on Congress to ensure that Donald Trump removes the Pharma giveaways from the revised NAFTA text before Congress begins consideration of the deal.
Public Citizen's NAFTA 2.0 Text Analysis
Read our analysis of the NAFTA 2.0 Text relative to the changes we have demanded to stop NAFTA’s ongoing damage.
NAFTA 2.0 Pharma Patent Analysis
Read our analysis of the pharmaceutical related patent provisions of NAFTA 2.0.